Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

A Systematic and Meta-Analysis Study on the Prevalence of Tuberculosis and Relative Risk Factors for Prisoners in Iran

Author(s): Sedigheh Taherpour, Mojtaba Mousavi Bazzaz, Hamidreza Naderi, Saeed Samarghandian, Alireza Amirabadizadeh, Tahereh Farkhondeh and Farshid Abedi*

Volume 22, Issue 1, 2022

Published on: 03 December, 2021

Article ID: e130921196422 Pages: 8

DOI: 10.2174/1871526521666210913111612

Price: $65

Abstract

Introduction: Tuberculosis (TB) is a serious infectious disease that affects human health globally. The incidence of TB in prisons is usually much higher than the general population in different countries. The aim of this study was to evaluate the incidence of TB among prisoners in Iran, estimating the relative risk factors by performing a systematic and meta-analysis study on the related articles.

Methodology: Our systematic and meta-analysis study was performed according to the PRISMA guidelines. Two authors systematically searched Scopus, Iran doc, Cochrane, Pubmed, Medline, Embase, Iran medex, Magiran, SID, Google Scholar, and EBSCO. The quality assessment of articles was performed by using the Newcastle-Ottawa Scale. After article quality assessment, a fixed or random model, as appropriate, was used to pool the results in a meta-analysis. Heterogeneity between the studies was assessed using I-square and Q-test. Forest plots demonstrating the point and pooled estimates were drawn.

Results: Overall, data from 19562 prisoners indicated 63 cases of TB. The prevalence of TB in prisoners was reported to range from 0.025% to 52% in eight studies. The highest prevalence of tuberculosis was related to the study of Rasht, 517 in 100,000, and the lowest rate was related to the study of Sought Khorasan, 25 in 100,000. The ES of the random effect model is 0.003 (95% CI, 0.001-0.005) and p-value <0.0001. The Higgins’ I2 of all studies is 86.55%, and the p-value of the Cochrane Q statistics is <0.001, indicating that there is heterogeneity. Based on the Egger regression plot (t=2.18, p = 0.08, CI 95%: -0.001, 0.005), no publication bias existed.

Conclusion: According to the analysis findings, the frequency of tuberculosis among the prison in Iran was low. The highest prevalence obtained in our systematic study was 517 in 100,000 in Rasht, which was near the world statistics in the systematic review of world studies. Due to significant limitations in this study, it is not possible to indicate the exact prevalence of TB in prisons in Iran and compare this with the general population. However, more studies are needed to assess the related risk factors for designing health intervention plans to decrease the incidence rate of TB among prisoners.

Keywords: Tuberculosis (TB), prison, HIV, risk factors, prevalence, AIDS.

Graphical Abstract

[1]
Niveau G. Prevention of infectious disease transmission in correctional settings: A review. Public Health 2006; 120(1): 33-41.
[http://dx.doi.org/10.1016/j.puhe.2005.03.017] [PMID: 16129465]
[2]
Stuckler D, Basu S, McKee M, King L. Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci USA 2008; 105(36): 13280-5.
[http://dx.doi.org/10.1073/pnas.0801200105] [PMID: 18728189]
[3]
Neshati H, Sheybani F, Naderi H, Sarvghad M, Soltani AK, Efterkharpoor E. Diagnostic errors in tuberculous patients: A multicenter study from a developing country. J. Environm. Public Health 2018; 2018.
[http://dx.doi.org/10.1155/2018/1975931]
[4]
Samarghandian S, Azimi‐Nezhad M, Farkhondeh T. Thymoquinone-induced antitumor and apoptosis in human lung adenocarcinoma cells. J Cell Physiol 2019; 234(7): 10421-31.
[http://dx.doi.org/10.1002/jcp.27710]
[5]
Olaleye AO, Beke AK. Survival of smear-positive multidrug resistant tuberculosis patients in Witbank, South Africa: A retrospective cohort study. Infect Dis (Lond) 2016; 48(6): 422-7.
[http://dx.doi.org/10.3109/23744235.2016.1153806] [PMID: 26954520]
[6]
Kassraian L. SadeghiHassanAbadi A. A survey on information of physicians in health center in Shiraz about infectious diseases (Tuberculosis, brucella, typhoid fever, dysentery) (1999). Indian J Med Educ 2000; 1(2): 38-42.
[7]
Story A, Murad S, Roberts W, Verheyen M, Hayward AC. Tuberculosis in London: The importance of homelessness, problem drug use and prison. Thorax 2007; 62(8): 667-71.
[http://dx.doi.org/10.1136/thx.2006.065409] [PMID: 17289861]
[8]
Ebrahimzadeh ET. Epidemiology of TB and its risk factors among prisoners in Birjand city in winter 1987. Iran J Clin Infect Dis 2014; 65: 37-3.
[9]
Peterson J, Welch V, Losos M, Tugwell P. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa. Ottawa Hospital Research Institute 2011; 1: 1-21.
[10]
Ansari M, Shahnazari H. Frequency of smear positive pulmonary tuberculosis in prisoners of central prison of hamadan in 1999. Avicenna J Clin Med 2001; 8(3): 1-10.
[11]
Ebrahimzadeh A, Eshaghi S, Bahlgerdi M, Hashemzehi M. , Eds Tuberculosis epidemiology in South Khorasan in 2000-2006. 18th national congress on tuberculosis. J Birjand Univ Med Sci 2009; 16(1): 31-9.
[12]
Haghshenas M, Mirmobini M, Babamahmodi F. Survey of the role of prevalence of tuberculosis and HIV in prisons of sari township in 1998-1999. J Maz Univ Med Sci 2000; 10(26): 33-7.
[13]
Moosazadeh M, Amiresmaili M, Parsaei M, Ahmadi M, Jalahi H. Prevalence of tuberculosis among the prisoners of Mazandaran. Majallah-i Ilmi-i Danishgah-i Ulum-i Pizishki-i Rafsanjan 2011; 10(4): 309-16.
[14]
Salek S, Velayati A, Masjedi M, Taghizadeh-Asl R, Yazdanpanah M. pulmonary tuberc ulosis at evin and qasr prisons. Journal of Medical Council of IR Iran 2001; 19: 90-4.
[15]
Taramian S, Jouafshani M. Determination of cyclical prevalence and evaluation of sputum positive pulmonary Tuberculosis in Lakan Prison in Rasht City. MJIRI 2005; 23(3): 265-72.
[16]
Asefzadeh M, Farrokhi A. Determining tuberculosis prevalence rate among Qazvin district prisoners. Iran J Infect Dis Trop Med 2001; 15(6): 58-63.
[17]
Nazer MR, Vaziri S, Janbakhsh A. The prevalence of smears positive pulmonary tuberculosis in a prison. Yafte 2015; 17(1): 15-27.
[18]
Rueda ZV, López L, Vélez LA, et al. High incidence of tuberculosis, low sensitivity of current diagnostic scheme and prolonged culture positivity in four colombian prisons. A cohort study. PLoS One 2013; 8(11)e80592
[http://dx.doi.org/10.1371/journal.pone.0080592] [PMID: 24278293]
[19]
Hosseini SMJ, Morovvati S, Ghadiani MH, Ranjbar R, Farnia M. Epidemiologic study of TB in Iranian prisons during April-September 2004. IJFM 2007; 13(1): 7-10.
[20]
Baghestani A, Maboudi A, Nasehi M, Teymourpour A. Tuberculosis trend in prison of Iran during 2005-2013. Iran J Infec Dis 2012; 23(68)
[21]
Assefzadeh M, Barghi RG, Shahidi ShS. Tuberculosis case--finding and treatment in the central prison of Qazvin province, Islamic Republic of Iran. East Mediterr Health J 2009; 15(2): 258-63.
[http://dx.doi.org/10.26719/2009.15.2.258] [PMID: 19554970]
[22]
Toungoussova OS, Mariandyshev A, Bjune G, Sandven P, Caugant DA. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: Predominance of the W-Beijing clone family. Clin Infect Dis 2003; 37(5): 665-72.
[http://dx.doi.org/10.1086/377205] [PMID: 12942398]
[23]
Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: A systematic review. PLoS Med 2010; 7(12)e1000381
[http://dx.doi.org/10.1371/journal.pmed.1000381] [PMID: 21203587]
[24]
Health Ministry Statistics Available from:. http://screening.health.gov.ir/SitePages/Home.aspx
[25]
Moges B, Amare B, Asfaw F, et al. Prevalence of smear positive pulmonary tuberculosis among prisoners in North Gondar Zone Prison, northwest Ethiopia. BMC Infect Dis 2012; 12(1): 352.
[http://dx.doi.org/10.1186/1471-2334-12-352] [PMID: 23241368]
[26]
Barnhoorn F, Adriaanse H. In search of factors responsible for noncompliance among tuberculosis patients in Wardha District, India. Soc Sci Med 1992; 34(3): 291-306.
[http://dx.doi.org/10.1016/0277-9536(92)90271-Q] [PMID: 1557670]
[27]
Steiner A, Mangu C, van den Hombergh J, et al. Screening for pulmonary tuberculosis in a Tanzanian prison and computer-aided interpretation of chest X-rays. Public Health Action 2015; 5(4): 249-54.
[http://dx.doi.org/10.5588/pha.15.0037] [PMID: 26767179]
[28]
Adane K, Spigt M, Ferede S, Asmelash T, Abebe M, Dinant G-J. Half of pulmonary tuberculosis cases were left undiagnosed in prisons of the Tigray region of Ethiopia: Implications for tuberculosis control. PLoS One 2016; 11(2)e0149453
[http://dx.doi.org/10.1371/journal.pone.0149453] [PMID: 26914770]
[29]
Vinkeles Melchers NV, van Elsland SL, Lange JM, Borgdorff MW, van den Hombergh J. State of affairs of tuberculosis in prison facilities: A systematic review of screening practices and recommendations for best TB control. PLoS One 2013; 8(1)e53644
[http://dx.doi.org/10.1371/journal.pone.0053644] [PMID: 23372662]
[30]
Pfyffer GE, Strässle A, van Gorkum T, et al. Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis 2001; 7(5): 855-61.
[http://dx.doi.org/10.3201/eid0705.017514] [PMID: 11747699]
[31]
Addis Z, Adem E, Alemu A, et al. Prevalence of smear positive pulmonary tuberculosis in Gondar prisoners, North West Ethiopia. Asian Pac J Trop Med 2015; 8(2): 127-31.
[http://dx.doi.org/10.1016/S1995-7645(14)60302-3] [PMID: 25902026]
[32]
Farkhondeh T, Folgado SL, Pourbagher-Shahri AM, Ashrafizadeh M, Samarghandian S. The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway. Biomed Pharmacotherapy 2020; 127110234
[http://dx.doi.org/10.3390/molecules26113157]
[33]
Al-Darraji HAA, Tan C, Kamarulzaman A, Altice FL. Prevalence and correlates of latent tuberculosis infection among employees of a high security prison in Malaysia. Occup Environ Med 2015; 72(6): 442-7.
[http://dx.doi.org/10.1136/oemed-2014-102695] [PMID: 25794506]

Rights & Permissions Print Cite
Article Metrics
30
1
© 2024 Bentham Science Publishers | Privacy Policy